Hot Topics in Diabetes and Endocrinology for Primary Care
Welcome, and thank you for attending the California Chapter of the American Association of Clinical Endocrinologists Hot Topics in Diabetes and Endocrinology for Primary Care Program in Cerritos, CA.
The California Chapter of AACE program committee has worked very hard to provide a relevant activity for the practicing clinical physician and other healthcare providers seeking education with an emphasis in endocrine disease.
This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.
Providing exceptional patient care requires continuing high quality education. The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. The impetus behind AACE's efforts has always been quality and cost-effective patient care for those with endocrine diseases and disorders. We hope that you will find this program of great value to you in your practice.
Family Practice, Internal Medicine Physicians, Nurse Practitioners, Physician Assistants and other health care professionals interested in the treatment of diabetes and other common endocrine diseases living in and around Cerritos, CA.
- After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and current healthcare practices.
- How to implement the 2018 AACE Diabetes Algorithm into your practice
- Evaluating options with focus on incorporating SGLT2 Inhibitors and GLP-1ra's into therapy
- Case scenario requiring addition of SGLT2i
- Case scenario requiring GLP1ra
- Recognize when advanced Beta Cell failure is present and basal insulin is necessary
- Know when the newer basal insulin formulations are indicated and how to use these with other agents such as GLP-1 agonists
- Case scenario requiring insulin initiation
- Case scenario requiring insulin or additional agent intensification
- Incorporate the newest methods to collect and interpret blood glucose data in your practice
- Identify key components in evaluating the ambulatory glucose profile in order to minimize glucose variability and hypoglycemia of patients with diabetes
- Case scenario with marked hypo and hyper-glycemia with a normal A1C
- Case scenario differentiating Somogi phenomenon with Dawn phenomenon
- Case scenario of a patient on MDI regimen who is not performing SBGM often enough
- Discuss current DM medications with proven CV risk reduction independent of glucose lowering
- Is time to look beyond glycemic control?
- Case scenario with Diabetic patient s/p MI who needs additional therapy (may be complicated by renal insufficiency)
- Case scenario with Diabetic patient s/p Stroke and history of compensated CHF and normal renal function
- Introduce the New AACE Lipid Guidelines
- Incorporate new agents to lower LDL cholesterol into a treatment paradigm
- Case scenario with Statin Intolerant patient
- Case study with patient who has Secondary Hyperlipidemia
- Case scenario with patient who has Heterozygous FHH
- Case scenario for Extremely High Risk patient
- Identify key components of thyroid function studies in different clinical situations
- Understand the values and pitfalls of Thyroid Ultrasound and thyroid Scan
- Case scenario with Patient in Pregnancy
- Case scenario with Patient with Subclinical Hypothyroidism
- Case scenario with Subacute Thyroiditis
- Case scenario with Hyperthyroidism
- Case scenario with an Incidental Thyroid Nodule
- At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
* Please click on the presentation title to view available materials.
Saturday, March 24, 2018
|7:00 – 7:45 AM||Breakfast / Registration|
|7:45 – 8:00 AM||Welcome & Pre-Meeting Assessment|
|8:00 – 8:30 AM||AACE Diabetes Algorithm-with Focus on SGLT2 Inhibitors|
and GLP-1 Therapies
Matthew Levine, MD, FACE
|8:30 – 9:00 AM||Insulin Initiation and Intensification with Focus on Hypoglycemia Reduction|
Michael Bush, MD
|9:00 – 9:30 AM||Incorporating CGM into Clinical Decision Making|
Jeff Unger, MD, FACE
|9:30 – 10:00 AM||Cardiovascular Outcome Studies, Is It Time for Paradigm Shift?|
Yehuda Handelsman, MD, FACP, FNLA, MACE
|10:00 – 10:15 AM||Panel Discussion|
|10:15 – 10:45 AM||Break|
|10:45 – 11:15 AM||Management of Hyperlipidemia Beyond Statins|
Chris Guerin, MD, FNLA, FACE
|11:15 – 11:45 AM||Thyroid Conundrums|
Herbert Rettinger, MD, FACE
|11:45 – 12:15 PM||Panel Discussion|
|12:15 – 12:45 PM||Post Meeting Assessment|
Michael A. Bush, MD
Clinical Chief, Division of Endocrinology, Cedars-Sinai Medical Center
Founding Director, Cedars-Sinai Weight Control Program and Diabetes Outpatient
Training & Education Center
Clinical Associate Professor of Medicine, Geffen School of Medicine, UCLA
Los Angeles, CA
*Chris K. Guerin, MD, FACE
Assistant Clinical Professor of Medicine
University of California, San Diego
Yehuda Handelsman, MD, FACP, FNLA, MACE
Medical Director & Principal Investigator, Metabolic Institute of America
Past President, ACE & AACE
Matthew J. Levine, MD, FACE
Scripps Clinic, Division of Diabetes/Endocrinology
Endocrinology Fellowship Director, Scripps Clinic/Scripps Green Hospital
Voluntary Assistant Clinical Professor of Medicine
U.C. San Diego School of Medicine
La Jolla, CA
Herbert I. Rettinger, MD, FACE
Past President, CA-AACE
Clinical Professor of Medicine/Endocrinology
University of California, Irvine, Volunteer Faculty 1977-2015
President, Endocrinology Medical Group of Orange County, Inc.
Orange County, CA
Jeff Unger, MD, FACE
Director, Metabolic Studies
Catalina Research Institute
Assistant Clinical Professor of Family Medicine;
UC Riverside School of Medicine
Director, Unger Primary Care Concierge Medical Group
Rancho Cucamonga, CA
*Indicates both a member of the Program Committee and faculty.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association of Clinical Endocrinologists (AACE) and the California Chapter of AACE. AACE is accredited by the ACCME to provide continuing medical education for physicians.
The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 4.50 AMA
- 4.50 Attendance